Home
Conditions
Newly Diagnosed

Clinical trial condition

Newly Diagnosed

Explore clinical trials studying Newly Diagnosed. Study availability and eligibility vary by location and protocol.

18 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Newly Diagnosed trial results

Recruiting

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

NCT02677064

Conditions: Acute Leukemia, Disease Attributes, Newly Diagnosed, +4 more
Locations: Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States

Memorial Sloan Kettering Cancer Center New York, United States

Lehigh Valley Health Network Allentown, Pennsylvania, United States

View Trial Details

Recruiting

Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).

NCT07561892

Conditions: Acute Myeloid Leukemia, Chemotherapy Effect, Hematologic Diseases, +7 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Recruiting

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

NCT05566054

Conditions: Acute Monocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: The First Affliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia

NCT06532552

Conditions: Acute Myeloid Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: The First Affliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

NCT06409702

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma

NCT06553352

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

NCT05833893

Conditions: Advanced Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +6 more
Locations: ChinaPLAGH Beijing, Haidian, China

View Trial Details

Not Yet Recruiting

CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?

NCT07070934

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible

NCT07070960

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)

NCT05284591

Conditions: Behavior, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: Centrum für Hämatologie und Onkologie Bethanien Frankfurt am Main, Hesse, Germany

View Trial Details

Newly Diagnosed

Newly Diagnosed trial results

Related conditions